Shugeng Zhang

机构：University of Science and Technology of China, Anhui Medical University, First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Bengbu Medical College, Hefei First People's Hospital · ORCID：0000-0001-9832-9784

发表论文 60 篇 · 总被引 1715 次 · h-index 16

代表论文

• RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma (2025 · Nature Cancer · 被引 24)
• Commensal-driven serotonin production modulates in vivo delivery of synthetic and viral vectors (2026 · Science · 被引 13)
• Enhanced recovery after liver transplantation—a prospective analysis focusing on quality assessment (2024 · HepatoBiliary Surgery and Nutrition · 被引 10)
• Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study (2025 · Gut · 被引 8)
• Glycolytic enzyme PFKFB4 governs lipolysis by promoting de novo lipogenesis to drive the progression of hepatocellular carcinoma (2025 · Cancer Letters · 被引 8)
• Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma (2025 · Cancer Immunology Immunotherapy · 被引 4)